Select Page

Acinetobacter species

Home Forums Infexion Connexion Acinetobacter species

Viewing 5 posts - 1 through 5 (of 5 total)
  • Author
    Posts
  • #77718
    Anonymous
    Inactive

    Author:
    Anonymous

    Position:

    Organisation:

    State:

    HI everyone
    ID team have just recommended that we isolate in contact precautions an ICU patient with a sensitive Acinetobacter Baumannii in his sputum . Currently we only isolate and used contact transmission based precautions for multi resistant Acinetobacter Species.
    The NHMRC guidelines do not include this pathogen in Section 6.4 Type and duration of precautions for specific infections and conditions .

    Until now we have always managed this pathogen using standard precautions when it is sensitive and in contact precautions when resistant.

    Can you let you how you manage patients with this pathogen in your hospital? Do you include this pathogen in your transmission based precautions guidelines?
    Regards

    Cate Coffey
    RN BaAScN MPH&TM Grad Cert Infection Control Nursing
    Clinical Nurse Manager

    Central Australia Health Service
    Department of Health
    Northern Territory Government

    Infection Prevention and Control Unit
    Alice Springs Hospital
    PO Box 2234, Alice Springs, NT 0871
    cate.coffey@nt.gov.au

    t. 08 8951 7737
    http://www.health.nt.gov.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    #77719
    Anonymous
    Inactive

    Author:
    Anonymous

    Position:

    Organisation:

    State:

    Hi Cate,
    Unless it is an MRAB, we manage with standard precautions even in ICU. Perhaps you might ask the Intensivist his reasons for isolating? Often they just see Acinetobacter baumanii and isolate without realising it’s not multiresistant? (Apologies if you’ve already done that).
    Regards,
    Rita
    Clinical Nurse Consultant | Infection Control
    Hornsby Ku ring gai Health Service, Palmerston Road, Hornsby NSW 2076
    Tel (02) 94856581 | Rita.Roy@health.nsw.gov.au
    http://www.health.nsw.gov.au

    Click here to visit the Infection Prevention and Control page on the Intranet

    [cid:image001.jpg@01D47A96.4139D820]

    [New signature block]

    HI everyone
    ID team have just recommended that we isolate in contact precautions an ICU patient with a sensitive Acinetobacter Baumannii in his sputum . Currently we only isolate and used contact transmission based precautions for multi resistant Acinetobacter Species.
    The NHMRC guidelines do not include this pathogen in Section 6.4 Type and duration of precautions for specific infections and conditions .

    Until now we have always managed this pathogen using standard precautions when it is sensitive and in contact precautions when resistant.

    Can you let you how you manage patients with this pathogen in your hospital? Do you include this pathogen in your transmission based precautions guidelines?
    Regards

    Cate Coffey
    RN BaAScN MPH&TM Grad Cert Infection Control Nursing
    Clinical Nurse Manager

    Central Australia Health Service
    Department of Health
    Northern Territory Government

    Infection Prevention and Control Unit
    Alice Springs Hospital
    PO Box 2234, Alice Springs, NT 0871
    cate.coffey@nt.gov.au

    t. 08 8951 7737
    http://secure-web.cisco.com/18j_6perAK4BtTUNQVlxaNhY0qLgYUPbL55NoaRWnLQhW3xDSGf2aDKEwDUY1vbnIqjsXmNgLKdQJWfOs0xqU0pM7qo-36vh1SIRjPZn06OPEQ8BrwMK3TZkTwnhOcnyZS3ns4dKXfCnkc09fnmHKHdp5dG3O6GadRQlgoaYvlZwjbNrrVytLZh9eHMUFslR5sH8SoF6dnexP4AxPnvk8KIu3LCRuitzKFinlhJYVRzoB2ysfyrrGxXgUvS_BTjCcbYeACMWIZbOw7hPNGUT-S0chpl9idCgltCJzum5MS19ipwCO-aqYttUMnTCJvf7Vfvo4RV0RWWyR2yrDwl_On3FEfmCy00tYpNj0BUUPquX9iqZe3cmRdnQ7JUbinVF_iYvhT74ewnw1IjYfVomOsRFmQK_E7ybFnimsHG7NiDhSLQzPDHIfVRG9o_JXYN6QpBDkg7a5K1NmWnS6mdNAzavdQ3NeuQtGMgUuNPCS9uc/http%3A%2F%2Fwww.health.nt.gov.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://secure-web.cisco.com/1NAN6p9Wyf-E_bbPSUiKtE6qYYiKJauAZ7rrxeP96rTS9SJdwI0MztSZ-vCNTPUU1jb9yJ7IXKMcAcMrY_S412rrlbAECKYIaBlnCcM-Qkd5IEsnHm0FpusEwJeFLVakSPzOefhVLLhXyJXXskdshBZG76oZnOYe-70lnlBuGbi6sJTJeR55hx2XEzA6-QxbZw62F3CdqqX9hyuusSak0ZVyLsL9gzSVWbGHt2RWW5Pytl3dOk8qDCiIXym6-7ZY5h1guVMU-q2YmCSceAPfkGHPKBXlp784JQFFKJLG_eK-9L3L5PwIL1TxeE8-V8Vn6-ERbY77ccf6ZkEZrPHn6mRzlrOuch_CoyPrtCmIOX1cdd1aeWPlPm2ru4O3pQCDhrResVh_SnDapLF9DGWrxkz5qbT1QXNUhQQkAfO2yjPnZgDWzN2Z1oYAacrMXI3Ic3G17payqeNYhijP_oonMYfYHRAM1xARE6TZTGvHTmxc/http%3A%2F%2Faicalist.org.au%2Farchives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    This message is intended for the addressee named and may contain confidential information. If you are not the intended recipient, please delete it and notify the sender.

    Views expressed in this message are those of the individual sender, and are not necessarily the views of NSW Health or any of its entities.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    #77720
    Marlize Senekal
    Participant

    Author:
    Marlize Senekal

    Position:

    Organisation:

    State:

    Good morning Cate and Rita,

    It would be best to discuss with the ID Team the reason for requesting isolation due to the nature of Acinetobacter and its ability to become resistant quickly. The person might have been treated with broad spectrum antimicrobials adding to the risk.
    Acinetobacter has been associated with many outbreaks in ICUs across the world and is very hard to eradicate once in a unit.

    Kind regards
    Marlize

    Marlize Senekal
    Infection Prevention and Control Clinical Nurse Consultant
    Residential Aged Care Support Services

    M 0418 866 816 | E MSenekal@wmq.org.au | http://www.wmq.org.au
    Central Offices – Wheller Gardens: 930 Gympie Road, Chermside QLD 4032

    Wesley Mission Queensland respectfully acknowledge the Traditional Custodians of the lands on which we work and live. We acknowledge Elders both past and present, whose ongoing effort to protect and promote Aboriginal and Torres Strait Islander cultures will leave a lasting legacy for future Elders and leaders.
    [cid:image001.gif@01D7010F.7C2362B0]

    [cid:image003.gif@01D7010F.7C2362B0] [cid:image004.gif@01D7010F.7C2362B0] [cid:image005.gif@01D7010F.7C2362B0] [cid:image006.gif@01D7010F.7C2362B0] [cid:image007.gif@01D7010F.7C2362B0] [cid:image008.gif@01D7010F.7C2362B0] [cid:image009.gif@01D7010F.7C2362B0]

    ________________________________
    Hi Cate,
    Unless it is an MRAB, we manage with standard precautions even in ICU. Perhaps you might ask the Intensivist his reasons for isolating? Often they just see Acinetobacter baumanii and isolate without realising it’s not multiresistant? (Apologies if you’ve already done that).
    Regards,
    Rita
    Clinical Nurse Consultant | Infection Control
    Hornsby Ku ring gai Health Service, Palmerston Road, Hornsby NSW 2076
    Tel (02) 94856581 | Rita.Roy@health.nsw.gov.au
    http://www.health.nsw.gov.au

    Click here to visit the Infection Prevention and Control page on the Intranet

    [cid:image001.jpg@01D47A96.4139D820]

    [New signature block]

    HI everyone
    ID team have just recommended that we isolate in contact precautions an ICU patient with a sensitive Acinetobacter Baumannii in his sputum . Currently we only isolate and used contact transmission based precautions for multi resistant Acinetobacter Species.
    The NHMRC guidelines do not include this pathogen in Section 6.4 Type and duration of precautions for specific infections and conditions .

    Until now we have always managed this pathogen using standard precautions when it is sensitive and in contact precautions when resistant.

    Can you let you how you manage patients with this pathogen in your hospital? Do you include this pathogen in your transmission based precautions guidelines?
    Regards

    Cate Coffey
    RN BaAScN MPH&TM Grad Cert Infection Control Nursing
    Clinical Nurse Manager

    Central Australia Health Service
    Department of Health
    Northern Territory Government

    Infection Prevention and Control Unit
    Alice Springs Hospital
    PO Box 2234, Alice Springs, NT 0871
    cate.coffey@nt.gov.au

    t. 08 8951 7737
    http://secure-web.cisco.com/18j_6perAK4BtTUNQVlxaNhY0qLgYUPbL55NoaRWnLQhW3xDSGf2aDKEwDUY1vbnIqjsXmNgLKdQJWfOs0xqU0pM7qo-36vh1SIRjPZn06OPEQ8BrwMK3TZkTwnhOcnyZS3ns4dKXfCnkc09fnmHKHdp5dG3O6GadRQlgoaYvlZwjbNrrVytLZh9eHMUFslR5sH8SoF6dnexP4AxPnvk8KIu3LCRuitzKFinlhJYVRzoB2ysfyrrGxXgUvS_BTjCcbYeACMWIZbOw7hPNGUT-S0chpl9idCgltCJzum5MS19ipwCO-aqYttUMnTCJvf7Vfvo4RV0RWWyR2yrDwl_On3FEfmCy00tYpNj0BUUPquX9iqZe3cmRdnQ7JUbinVF_iYvhT74ewnw1IjYfVomOsRFmQK_E7ybFnimsHG7NiDhSLQzPDHIfVRG9o_JXYN6QpBDkg7a5K1NmWnS6mdNAzavdQ3NeuQtGMgUuNPCS9uc/http%3A%2F%2Fwww.health.nt.gov.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://secure-web.cisco.com/1NAN6p9Wyf-E_bbPSUiKtE6qYYiKJauAZ7rrxeP96rTS9SJdwI0MztSZ-vCNTPUU1jb9yJ7IXKMcAcMrY_S412rrlbAECKYIaBlnCcM-Qkd5IEsnHm0FpusEwJeFLVakSPzOefhVLLhXyJXXskdshBZG76oZnOYe-70lnlBuGbi6sJTJeR55hx2XEzA6-QxbZw62F3CdqqX9hyuusSak0ZVyLsL9gzSVWbGHt2RWW5Pytl3dOk8qDCiIXym6-7ZY5h1guVMU-q2YmCSceAPfkGHPKBXlp784JQFFKJLG_eK-9L3L5PwIL1TxeE8-V8Vn6-ERbY77ccf6ZkEZrPHn6mRzlrOuch_CoyPrtCmIOX1cdd1aeWPlPm2ru4O3pQCDhrResVh_SnDapLF9DGWrxkz5qbT1QXNUhQQkAfO2yjPnZgDWzN2Z1oYAacrMXI3Ic3G17payqeNYhijP_oonMYfYHRAM1xARE6TZTGvHTmxc/http%3A%2F%2Faicalist.org.au%2Farchives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    This message is intended for the addressee named and may contain confidential information. If you are not the intended recipient, please delete it and notify the sender.

    Views expressed in this message are those of the individual sender, and are not necessarily the views of NSW Health or any of its entities.
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    #77721
    Jayne OConnor
    Participant

    Author:
    Jayne OConnor

    Position:

    Organisation:

    State:

    Hi Cate,

    we only isolate and initiate contact precautions if the Acinetobacter is multi drug resistant, maybe question the ID physician as he may have another reason for isolation?
    Would be interested to know their response. Good luck

    Jayne

    Jayne O’Connor RN ,BSc.,Inf.Cont
    IPC Co-Ordinator
    Sydney Adventist Hospital | 185 Fox Valley Road, Wahroonga, NSW 2076

    p: +61 2 9480 9732 | f: +61 2 9470 8052 | m: +61 0406 752685 | e: jayne.oconnor@sah.org.au
    http://www.sah.org.au
    [cid:image001.png@01D70440.B6249DB0]
    [1_twitter] [2_linkedIn] [3_facebook] [4_insta] [5_youtube]

    HI everyone
    ID team have just recommended that we isolate in contact precautions an ICU patient with a sensitive Acinetobacter Baumannii in his sputum . Currently we only isolate and used contact transmission based precautions for multi resistant Acinetobacter Species.
    The NHMRC guidelines do not include this pathogen in Section 6.4 Type and duration of precautions for specific infections and conditions .

    Until now we have always managed this pathogen using standard precautions when it is sensitive and in contact precautions when resistant.

    Can you let you how you manage patients with this pathogen in your hospital? Do you include this pathogen in your transmission based precautions guidelines?
    Regards

    Cate Coffey
    RN BaAScN MPH&TM Grad Cert Infection Control Nursing
    Clinical Nurse Manager

    Central Australia Health Service
    Department of Health
    Northern Territory Government

    Infection Prevention and Control Unit
    Alice Springs Hospital
    PO Box 2234, Alice Springs, NT 0871
    cate.coffey@nt.gov.au

    t. 08 8951 7737
    http://www.health.nt.gov.au

    Email has been scanned by the AHCL Mail Filtering service, click here to report this as spam or malicious email.
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    This message has been scanned for malware by Forcepoint. http://www.forcepoint.com

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    #77722
    dr.asmaa_hagag@yahoo.com
    Participant

    Author:
    dr.asmaa_hagag@yahoo.com

    Position:

    Organisation:

    State:

    Dear my Respected Colleagues
    Acinetobacter have the intrinsic ability to turned resistant very quickly so , contact isolation precautions would be recommended from day 1 admission …..to avoid un intended outbreaks
    Thank you
    Dr Asmaa HagagInfection control consultant ,CICKing Abdullah Medical CitySaudi Arabia

    Sent from Yahoo Mail on Android
    On Tue, 16 Feb 2021 at 12:53 am, Jayne OConnor wrote: #yiv8348119132 #yiv8348119132 — _filtered {} _filtered {} _filtered {}#yiv8348119132 #yiv8348119132 p.yiv8348119132MsoNormal, #yiv8348119132 li.yiv8348119132MsoNormal, #yiv8348119132 div.yiv8348119132MsoNormal {margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;}#yiv8348119132 a:link, #yiv8348119132 span.yiv8348119132MsoHyperlink {color:#0563C1;text-decoration:underline;}#yiv8348119132 a:visited, #yiv8348119132 span.yiv8348119132MsoHyperlinkFollowed {color:#954F72;text-decoration:underline;}#yiv8348119132 p {margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:New;}#yiv8348119132 p.yiv8348119132MsoAcetate, #yiv8348119132 li.yiv8348119132MsoAcetate, #yiv8348119132 div.yiv8348119132MsoAcetate {margin:0cm;margin-bottom:.0001pt;font-size:8.0pt;}#yiv8348119132 span.yiv8348119132EmailStyle17 {color:windowtext;}#yiv8348119132 span.yiv8348119132EmailStyle19 {color:#1F497D;}#yiv8348119132 span.yiv8348119132BalloonTextChar {}#yiv8348119132 .yiv8348119132MsoChpDefault {font-size:10.0pt;} _filtered {}#yiv8348119132 div.yiv8348119132WordSection1 {}#yiv8348119132
    Hi Cate,

    we only isolate and initiate contact precautions if the Acinetobacter is multi drug resistant, maybe question the ID physician as he may have another reason for isolation?
    Would be interested to know their response. Good luck

    Jayne

    Jayne O’Connor RN ,BSc.,Inf.Cont
    IPC Co-Ordinator
    Sydney Adventist Hospital | 185 Fox Valley Road, Wahroonga, NSW 2076

    p: +61 2 9480 9732| f:+612 9470 8052| m: +61 0406 752685 | e: jayne.oconnor@sah.org.au
    http://www.sah.org.au

    HI everyone
    ID team have just recommended that we isolate in contact precautions an ICU patient with a sensitive Acinetobacter Baumannii in his sputum . Currently we only isolate and used contact transmission based precautions for multi resistant Acinetobacter Species.
    The NHMRC guidelines do not include this pathogen in Section 6.4Type and duration of precautions for specific infections and conditions .

    Until now we have always managed this pathogen using standard precautions when it is sensitive and in contact precautions when resistant.

    Can you let you how you manage patients with this pathogen in your hospital? Do you include this pathogen in your transmission based precautions guidelines?
    Regards

    Cate Coffey
    RN BaAScN MPH&TM Grad Cert Infection Control Nursing
    Clinical Nurse Manager

    Central Australia Health Service
    Department of Health
    Northern Territory Government

    Infection Prevention and Control Unit
    Alice Springs Hospital
    PO Box 2234, Alice Springs, NT 0871
    cate.coffey@nt.gov.au

    t. 08 8951 7737
    http://www.health.nt.gov.au

    Email has been scanned by the AHCL Mail Filtering service, clickhere to report this as spam or malicious email.
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    Replies to this message will be directed back to the list. To create a new message send an email toacipclist@acipc.org.au
    To send a message to the list administrator send an email to admin@acipc.org.au
    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) tolistserv@aicalist.org.au

    This message has been scanned for malware by Forcepoint. http://www.forcepoint.com
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

Viewing 5 posts - 1 through 5 (of 5 total)
  • The forums ‘Infexion Connexion’ is closed to new topics and replies.